Literature DB >> 8441581

Recurrent hemolytic uremic syndrome secondary to Escherichia coli O157:H7 infection.

R L Siegler1, P M Griffin, T J Barrett, N A Strockbine.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8441581

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  13 in total

1.  Comparison of the western blot assay with the neutralizing-antibody and enzyme-linked immunosorbent assays for measuring antibody to verocytotoxin 1.

Authors:  D Reymond; M A Karmali; I Clarke; M Winkler; M Petric
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

Review 2.  Are there restrictions to vaccinating a child who has recovered from hemolytic uremic syndrome?

Authors:  B S Kaplan
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

3.  Immunization of mice with chimeric antigens displaying selected epitopes confers protection against intestinal colonization and renal damage caused by Shiga toxin-producing Escherichia coli.

Authors:  David A Montero; Felipe Del Canto; Juan C Salazar; Sandra Céspedes; Leandro Cádiz; Mauricio Arenas-Salinas; José Reyes; Ángel Oñate; Roberto M Vidal
Journal:  NPJ Vaccines       Date:  2020-03-12       Impact factor: 7.344

4.  Passive immunity acquisition of maternal anti-enterohemorrhagic Escherichia coli (EHEC) O157:H7 IgG antibodies by the newborn.

Authors:  Patricia Palmeira; Leonardo Yu Ito; Christina Arslanian; Magda Maria Sales Carneiro-Sampaio
Journal:  Eur J Pediatr       Date:  2006-10-21       Impact factor: 3.183

5.  Another step forward in our understanding of the hemolytic uremic syndromes: tieing up some loose ends.

Authors:  B S Kaplan
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

6.  Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome.

Authors:  Kerstin Ludwig; Volkan Sarkim; Martin Bitzan; Mohamed A Karmali; Christoph Bobrowski; Hans Ruder; Rainer Laufs; Ingo Sobottka; Martin Petric; Helge Karch; Dirk E Müller-Wiefel
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

7.  Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome.

Authors:  K Ludwig; M A Karmali; V Sarkim; C Bobrowski; M Petric; H Karch; D E Müller-Wiefel
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

8.  Oral administration of Shiga toxin-producing Escherichia coli induces intestinal and systemic specific immune response in mice.

Authors:  Romina Jimena Fernandez-Brando; Gabriel Cabrera; Ariela Baschkier; María Pilar Mejías; Cecilia Analia Panek; Elizabeth Miliwebsky; María Jimena Abrey-Recalde; Leticia Verónica Bentancor; María Victoria Ramos; Marta Rivas; Marina Sandra Palermo
Journal:  Med Microbiol Immunol       Date:  2014-01-08       Impact factor: 3.402

Review 9.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

10.  Protection of mice against Shiga toxin 2 (Stx2)-associated damage by maternal immunization with a Brucella lumazine synthase-Stx2 B subunit chimera.

Authors:  María Pilar Mejias; Gabriel Cabrera; Romina Jimena Fernández-Brando; Ariela Baschkier; Giselle Ghersi; Maria Jimena Abrey-Recalde; Elizabeth Miliwebsky; Roberto Meiss; Fernando Goldbaum; Vanesa Zylberman; Marta Rivas; Marina Sandra Palermo
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.